Follow
Alastair Davies
Alastair Davies
Verified email at pfizer.com
Title
Cited by
Cited by
Year
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
JL Bishop, D Thaper, S Vahid, A Davies, K Ketola, H Kuruma, R Jama, ...
Cancer Discovery 7 (1), 54-71, 2017
3382017
Cellular plasticity and the neuroendocrine phenotype in prostate cancer
AH Davies, H Beltran, A Zoubeidi
Nature Reviews Urology 15 (5), 271-286, 2018
3262018
Spatial and temporal expression of the 23 murine Prolactin/Placental Lactogen-related genes is not associated with their position in the locus
DG Simmons, S Rawn, A Davies, M Hughes, JC Cross
BMC genomics 9 (1), 1-20, 2008
2342008
Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance
K To, A Fotovati, KM Reipas, JH Law, K Hu, J Wang, A Astanehe, ...
Cancer research 70 (7), 2840-2851, 2010
2062010
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
AL Stratford, CJ Fry, C Desilets, AH Davies, YY Cho, Y Li, Z Dong, ...
Breast Cancer Research 10 (6), 1-12, 2008
1692008
Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells
MR Finkbeiner, A Astanehe, K To, A Fotovati, AH Davies, Y Zhao, H Jiang, ...
Oncogene 28 (11), 1421-1431, 2009
1152009
Biological evolution of castration-resistant prostate cancer
A Davies, V Conteduca, A Zoubeidi, H Beltran
European urology focus 5 (2), 147-154, 2019
892019
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer
A Davies, S Nouruzi, D Ganguli, T Namekawa, D Thaper, S Linder, ...
Nature Cell Biology 23 (9), 1023-1034, 2021
802021
The epigenetic and transcriptional landscape of neuroendocrine prostate cancer
A Davies, A Zoubeidi, LA Selth
Endocrine-Related Cancer 27 (2), R35-R50, 2020
712020
Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
K Hu, C Lee, D Qiu, A Fotovati, A Davies, S Abu-Ali, D Wai, ER Lawlor, ...
Molecular cancer therapeutics 8 (11), 3024-3035, 2009
672009
YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification
AH Davies, I Barrett, MR Pambid, K Hu, AL Stratford, S Freeman, ...
Oncogene 30 (34), 3649-3660, 2011
602011
Regulation of tumor cell plasticity by the androgen receptor in prostate cancer
JL Bishop, A Davies, K Ketola, A Zoubeidi
Endocr Relat Cancer 22 (3), R165-R182, 2015
562015
Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells
AH Davies, K Reipas, K Hu, R Berns, N Firmino, AL Stratford, SE Dunn
Oncotarget 6 (24), 20570, 2015
442015
YB‐1 Transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal‐like breast cancer
AH Davies, KM Reipas, MR Pambid, R Berns, AL Stratford, A Fotovati, ...
Stem cells 32 (6), 1437-1450, 2014
432014
ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer
S Nouruzi, D Ganguli, N Tabrizian, M Kobelev, O Sivak, T Namekawa, ...
Nature communications 13 (1), 1-15, 2022
392022
CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer
M Ahmed, F Soares, JH Xia, Y Yang, J Li, H Guo, P Su, Y Tian, HJ Lee, ...
Nature communications 12 (1), 1-15, 2021
352021
Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition
K Ketola, RSN Munuganti, A Davies, KM Nip, JL Bishop, A Zoubeidi
Clinical Cancer Research 23 (22), 6923-6933, 2017
342017
Complex patterns of cell growth in the placenta in normal pregnancy and as adaptations to maternal diet restriction.
M Eaton, AH Davies, J Devine, X Zhao, DG Simmons, E Maríusdóttir, ...
PloS one 15 (1), e0226735, 2020
312020
Patient-derived xenografts: A platform for accelerating translational research in prostate cancer
AH Davies, Y Wang, A Zoubeidi
Molecular and cellular endocrinology 462, 17-24, 2018
292018
YB-1 drives preneoplastic progression: Insight into opportunities for cancer prevention
AH Davies, SE Dunn
Oncotarget 2 (5), 401, 2011
152011
The system can't perform the operation now. Try again later.
Articles 1–20